Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Using Infrared Spectroscopy to Analyze Volatile Organic Compounds in the Breath of Patients to Detect Breast Cancer

NCT06512350 is registered in ClinicalTrials.gov with Breathe BioMedical Inc as lead sponsor.

NCT NCT06512350
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06512350 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Using Infrared Spectroscopy to Analyze Volatile Organic Compounds in the Breath of Patients to Detect Breast Cancer
Lead sponsor
Breathe BioMedical Inc
Phase
Observational
Overall status
Recruiting
Start date
February 25, 2025
Completion date
February 29, 2028
Enrollment
5,175 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer